Skip to main content
Clinical Trials/IRCT20220317054318N2
IRCT20220317054318N2
Recruiting
Phase 3

Evaluate the effect of platelet-rich plasma(PRP) by testicular injection on spermogram parameters of infertile men with sever oligoasthenoteratozoospermia (OAT)

Hamedan University of Medical Sciences0 sites88 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Oligostenoteratozoospermia.
Sponsor
Hamedan University of Medical Sciences
Enrollment
88
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age range 20\-45 years.
  • sperm count less than 20 million,
  • Movement less than 106 x 5 ml, progressive movement \< 20%, normal morphology \< 10%

Exclusion Criteria

  • Receiving other treatments for oligospermia such as hormone therapy
  • Suffering from underlying diseases (such as diabetes, kidney disease, liver disease, drug and alcohol addiction) and types of cancer and receiving chemotherapy treatments

Outcomes

Primary Outcomes

Not specified

Similar Trials